These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21537664)

  • 21. [Phosphodiesterase type 5 inhibitors in the treatment of pulmonary arterial hypertension].
    Kiliçkesmez K; Küçükoğlu MS
    Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():16-8. PubMed ID: 20819751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sildenafil for pulmonary arterial hypertension: when blue turns into white.
    Antoniu SA
    Expert Opin Pharmacother; 2006 Sep; 7(13):1801-10. PubMed ID: 16925506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension].
    Sakuma M; Shirato K
    Nihon Rinsho; 2008 Nov; 66(11):2157-61. PubMed ID: 19051736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety, tolerability, and efficacy of overnight switching from sildenafil to tadalafil in patients with pulmonary arterial hypertension.
    Shapiro S; Traiger G; Hill W; Zhang L; Doran AK
    Cardiovasc Ther; 2013 Oct; 31(5):274-9. PubMed ID: 23841794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of sildenafil on survival of patients with idiopathic pulmonary arterial hypertension.
    Zeng WJ; Sun YJ; Gu Q; Xiong CM; Li JJ; He JG
    J Clin Pharmacol; 2012 Sep; 52(9):1357-64. PubMed ID: 21956607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment with sildenafil, bosentan, or both in children and young people with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome].
    Raposo-Sonnenfeld I; Otero-González I; Blanco-Aparicio M; Ferrer-Barba A; Medrano-López C
    Rev Esp Cardiol; 2007 Apr; 60(4):366-72. PubMed ID: 17521545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of sildenafil on haemodynamic parameters of pulmonary circulation and physical capacity in patients with systolic chronic heart failure with secondary severe pulmonary hypertension].
    Josiak K; Inorowicz E; Petruk-Kowalczyk J; Kremis E; Wilczyński J; Zymliński R; Biegus J; Jankowska E; Banasiak W; Ponikowski P
    Kardiol Pol; 2011; 69(5):517-9. PubMed ID: 21594853
    [No Abstract]   [Full Text] [Related]  

  • 28. The utility of sildenafil in pulmonary hypertension: a focus on bronchopulmonary dysplasia.
    Wardle AJ; Wardle R; Luyt K; Tulloh R
    Arch Dis Child; 2013 Aug; 98(8):613-7. PubMed ID: 23625986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical characteristics and outcome of 13 dogs with pulmonary arterial hypertension (PH) treated with sildenafil.
    Moreno HJ
    J Vet Intern Med; 2007; 21(6):1165. PubMed ID: 18196719
    [No Abstract]   [Full Text] [Related]  

  • 30. Sildenafil: a definitive NO in COPD.
    Vonk-Noordegraaf A; Boerrigter BG
    Eur Respir J; 2013 Oct; 42(4):893-4. PubMed ID: 24081756
    [No Abstract]   [Full Text] [Related]  

  • 31. Sildenafil for the treatment of pulmonary hypertension in children.
    Beghetti M; Wacker Bou Puigdefabregas J; Merali S
    Expert Rev Cardiovasc Ther; 2014 Oct; 12(10):1157-84. PubMed ID: 25223406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertension.
    Simonneau G; Rubin LJ; Galiè N; Barst RJ; Fleming TR; Frost A; Engel P; Kramer MR; Serdarevic-Pehar M; Layton GR; Sitbon O; Badesch DB;
    J Heart Lung Transplant; 2014 Jul; 33(7):689-97. PubMed ID: 24815795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sildenafil improves walk distance in idiopathic pulmonary fibrosis.
    Collard HR; Anstrom KJ; Schwarz MI; Zisman DA
    Chest; 2007 Mar; 131(3):897-899. PubMed ID: 17356110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic applications of sildenafil citrate in the management of paediatric pulmonary hypertension.
    Leibovitch L; Matok I; Paret G
    Drugs; 2007; 67(1):57-73. PubMed ID: 17209664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sildenafil citrate for the treatment of pulmonary hypertension.
    Hrometz SL; Shields KM
    Drugs Today (Barc); 2006 Dec; 42(12):771-84. PubMed ID: 17285150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sildenafil in idiopathic pulmonary fibrosis.
    Maher TM
    N Engl J Med; 2010 Nov; 363(22):2169; author reply 2170-1. PubMed ID: 21105804
    [No Abstract]   [Full Text] [Related]  

  • 37. Marked improvement with sildenafil in a patient with idiopathic pulmonary arterial hypertension unresponsive to beraprost and sarpogrelate.
    Kawano H; Sengyoku H; Satoh O; Urabe S; Koide Y; Yano K
    Intern Med; 2007; 46(12):893-8. PubMed ID: 17575385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of sildenafil in children with pulmonary arterial hypertension].
    He CY
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jun; 12(6):509-12. PubMed ID: 20540870
    [No Abstract]   [Full Text] [Related]  

  • 39. Sildenafil in the treatment of pulmonary hypertension.
    Barnett CF; Machado RF
    Vasc Health Risk Manag; 2006; 2(4):411-22. PubMed ID: 17323595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of long-term sildenafil therapy in a young dog with pulmonary hypertension.
    Toyoshima Y; Kanemoto I; Arai S; Toyoshima H
    J Vet Med Sci; 2007 Oct; 69(10):1073-5. PubMed ID: 17984597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.